PARTICULATE QUALITY OF A CONTROLLED ATMOSPHERE AREA. COMPLIANCE WITH GOOD MANUFACTURING PRACTICES AT REST AND DURING ACTIVITY, HIGHLIGHTING OF FACTORS IMPACTING ON CONTAMINATION (submitted in 2019)
3PC-021
STORAGE OF NIVOLUMAB, PEMBROLIZUMAB AND DARATUMUMAB FOR 14 DAYS AFTER COMPOUNDING IN THE HOSPITAL PHARMACY: A MICROBIOLOGICAL STABILITY STUDY (submitted in 2019)
3PC-020
PHYSICOCHEMICAL STABILITY OF 25 MG/ML PEMETREXED DIARGININE IN PARTIALLY-USED VIALS AND 3 AND 12 MG/ML DILUTED IN DEXTROSE 5% IN POLYOLEFIN BAG. (submitted in 2019)
3PC-019
IN USE PHYSICOCHEMICAL AND MICROBIOLOGICAL STABILITY OF DILUTED SOLUTIONS OF THE MONOCLONAL ANTIBODY NIVOLUMAB (submitted in 2019)
3PC-018
MITOMYCIN C STABILITY ACCORDING TO PH AND TEMPERATURE CONDITIONS (submitted in 2019)
3PC-017
INCREASING PHARMACY PRODUCTIVITY BY EXPANDING THE ROLE OF THE INTRAVENOUS COMPOUNDING ROBOT IN A COMPREHENSIVE CANCER CENTRE (submitted in 2019)
3PC-016
STABILITY OF COMPOUNDED NIVOLUMAB SOLUTION AFTER PNEUMATIC SYSTEM TRANSPORTATION (submitted in 2019)
3PC-015
SHORT TERM STABILITY OF DILUTED SOLUTIONS OF THE MONOCLONAL ANTIBODY DARATUMUMAB (submitted in 2019)
3PC-014
USE OF CABAZITAXEL AND REDUCTION OF WASTE: THE POTENTIAL OF DRUG-DAY. (submitted in 2019)
3PC-013
COMPARATIVE BIOPHYSICAL STABILITY STUDY OF ZIV-AFLIBERCEPT (ZALTRAP, OPENED VIALS) STORED AT 4ºC AND ROOM TEMPERATURE FOR 2 WEEKS (submitted in 2019)
3PC-012
MANAGEMENT OF NON-ADMINISTERED CHEMOTHERAPY PREPARATION: AN OPPORTUNITY TO MINIMISE DRUG WASTE IN ONCOLOGY PHARMACY (submitted in 2019)
3PC-011
CLOSED SYSTEM TRANSFER DEVICE BASED ON AIR FILTRATION: THE DRUG VAPOUR CHALLENGE (submitted in 2019)
3PC-010
EVALUATION OF THE PRODUCTION ACCURACY AND ERROR RATE IN THE AUTOMATED COMPOUNDING OF CYTOTOXIC PREPARATIONS BY A ROBOT (submitted in 2019)
3PC-009
TREATMENT OF RECURRENT OTOMYCOSIS WITH LOCAL APPLICATION OF A COMPOUNDED FORMULATION OF VORICONAZOLE EAR DROPS: CASE SERIES (submitted in 2019)
3PC-008
INTRAVENOUS PERFUSION OF CEFTOLOZANE-TAZOBACTAM USING ELASTOMERIC INFUSION PUMPS (submitted in 2019)
